首页> 外文期刊>The Australasian journal of dermatology >Atypical fibroxanthoma management: Recurrence, metastasis and disease‐specific death
【24h】

Atypical fibroxanthoma management: Recurrence, metastasis and disease‐specific death

机译:非典型肌瘤瘤管理:复发,转移和疾病特异性死亡

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Atypical fibroxanthoma (AFX) is a rare spindle cell neoplasm predominantly found on the head and neck of elderly individuals with sun‐damaged skin, with no evidence‐based guidelines for their management. A systematic retrospective review of the literature focusing on treatment modality found a recurrence and metastasis rate of 8.0% (5.6% when adjusted for incomplete excisions) and 0.5% for local excision and 4.6% and 3.2% for Mohs micrographic surgery, respectively. Our results suggest that with clear surgical margins, AFX is unlikely to recur and metastases are rare, with significantly higher rates in the immunosuppressed population.
机译:摘要非典型纤维瘤(AFX)是一种稀有的主轴细胞肿瘤,主要发现在老年人的头部和颈部有太阳损伤的皮肤,没有基于证据的管理指导。 对重点进行治疗方式的文献的系统回顾性审查发现,分别为8.0%的复发和转移率为8.0%(调整不完全自切除的5.6%),局部切除0.5%,分别为MOHS显微镜手术的4.6%和3.2%。 我们的研究结果表明,随着手术边缘清晰,AFX不太可能反转,转移罕见,免疫抑制人群中具有明显较高的速率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号